Omkar Speciality Chemicals forays into CRAMS business

Omkar Speciality Chemicals has planned to foray into Contract Research and Manufacturing Services (CRAMS) business to move up the value chain in the pharma industry with the help of its strong operational efficiencies backed by robust R&D focused initiatives and multi-product delivery capabilities.

The key growth drivers for the company in the CRAMS segment are strong order pipeline which will result into high margin commercial manufacturing opportunities, a growing client base that will help the company to sustainably build a diversified product portfolio and strengthen operational efficiencies driven by R&D focused initiatives as well as multi-product delivery capability.

Omkar Speciality Chemicals is one of the leading players in the manufacturing of Speciality Chemicals and Veterinary APIs. The company manufactures a range of Organic and Inorganic Intermediates.

However, on Monday, the stock opened at Rs. 7.68 on the BSE, which is its 52-week low. The stock had hit a 52-week high of Rs. 29.90 on January 21, 2019.